S. Berezowska

Discipline

Histoire, Philosophie et Sociologie des sciences (2) Economies et finances (2) Sociologie (1) Psychologie (1) Philosophie (1) Sciences de l'information et de la communication (1)

Type de document

Articles (40) Recensions (4)

Co-auteur

Date

Source

Mot-clé

Patients (26) Lungs (26) Patients (26) Treatment (21) Human beings (19) Lungs--Cancer (18) Cancer (18) survie (16) Therapeutics (16) Survival (16) thérapie (15) pathologie (14) Pathology (14) tissu (corporel) (13) Tumors (13) maladie (12) maladie (12) analyse (11) cancer (11) Cancer (11) Cells (11) Analysis (11) Expression (10) Chemotherapy (9) Inhibitors (9) Cases (9) Prognosis (9) Evaluation (9) Chemotherapy (9) Cases (9)

Documents écrit par S. Berezowska (40) | parle de S. Berezowska (0)

Pulmonary squamous cell carcinoma and lymphoepithelial carcinoma - morphology, molecular characteristics and differential diagnosis.
S. Berezowska et al.
Digital image analysis and artificial intelligence in pathology diagnostics-the Swiss view
S. Berezowska et al.
Spatial metabolomics identifies distinct tumor-specific and stroma-specific subtypes in patients with lung squamous cell carcinoma.
J. Wang et al. (2 nov. 2023)
Patterns of Carbon-Bound Exogenous Compounds Impact Disease Pathophysiology in Lung Cancer Subtypes in Different Ways.
J. Shen et al. (12 sept. 2023)
Overcoming the Interobserver Variability in Lung Adenocarcinoma Subtyping: A Clustering Approach to Establish a Ground Truth for Downstream Applications.
K. Lami et al. (1 août 2023)
Neoadjuvant treatment does not influence PD-L1 expression in stage III non-small-cell lung cancer: a retrospective analysis of tumor samples from the trials SAKK 16/96, 16/00, 16/01, and 16/14.
D. König et al. (11 juil. 2023)
Deep computational image analysis of immune cell niches reveals treatment-specific outcome associations in lung cancer.
C. Barrera et al. (1 juin 2023)
Integrated longitudinal analysis of adult grade 4 diffuse gliomas with long-term relapse interval revealed upregulation of TGF-β signaling in recurrent tumors.
E. Kashani et al. (6 avr. 2023)
MEK1 drives oncogenic signaling and interacts with PARP1 for genomic and metabolic homeostasis in malignant pleural mesothelioma.
H. Yang et al. (10 févr. 2023)
Immunogenomic analysis of human brain metastases reveals diverse immune landscapes across genetically distinct tumors.
Á.F. Álvarez-Prado et al. (17 janv. 2023)
The effect of neoadjuvant therapy on PD-L1 expression and CD8+lymphocyte density in non-small cell lung cancer.
P. Zens et al.
Major Pathologic Response and Prognostic Score Predict Survival in Patients With Lung Cancer Receiving Neoadjuvant Chemotherapy.
A. Pataer et al.
Programmed Death-Ligand 1 Expression in Lung Cancer and Paired Brain Metastases-a Single-Center Study in 190 Patients.
A. Kündig et al.
Image analysis reveals molecularly distinct patterns of TILs in NSCLC associated with treatment outcome.
R. Ding et al. (3 juin 2022)
Spatial metabolomics for evaluating response to neoadjuvant therapy in non-small cell lung cancer patients.
J. Shen et al.
The Octopus Sign-A New HRCT Sign in Pulmonary Langerhans Cell Histiocytosis.
A. Poellinger et al. (8 avr. 2022)
The cGAS-STING pathway drives type I IFN immunopathology in COVID-19.
J.D. Domizio et al.
COVID-19 Pulmonary Pathology: The Experience of European Pulmonary Pathologists throughout the First Two Waves of the Pandemic.
F. Fortarezza et al. (1 janv. 2022)
Patterns of Carbon-Bound Exogenous Compounds in Patients with Lung Cancer and Association with Disease Pathophysiology.
T. Kunzke et al. (1 déc. 2021)
Mutational profiles of primary pulmonary adenocarcinoma and paired brain metastases disclose the importance of KRAS mutations.
E. Vassella et al.
Update Thoraxpathologie 2021 – Bericht der Arbeitsgemeinschaft [Update on thoracic pathology 2021-report of the working group thoracic pathology of the German Society of Pathology]
S. Berezowska et al.
Chaperone-Mediated Autophagy Markers LAMP2A and HSPA8 in Advanced Non-Small Cell Lung Cancer after Neoadjuvant Therapy.
T. Losmanova et al. (13 oct. 2021)
A prognostic and predictive computational pathology image signature for added benefit of adjuvant chemotherapy in early stage non-small-cell lung cancer.
X. Wang et al.
A prognostic score for non-small cell lung cancer resected after neoadjuvant therapy in comparison with the tumor-node-metastases classification and major pathological response.
P. Zens et al.
CRISPR-Mediated Kinome Editing Prioritizes a Synergistic Combination Therapy for FGFR1-Amplified Lung Cancer.
Z. Yang et al. (1 juin 2021)

next